Brandon R. Lott’s Post

Looking forward to meeting #industryexecutives and #investors from around the world at the #jpm2024 in San Francisco. If you're in the area, it would be great to catch up and network. #Vamstar is transforming how the #buyers and #suppliers in the healthcare market operates by focusing on its essential components: #data, #tradinginfrastructure, #technology, #people, and #processes. We're revolutionising the industry's commerce in #medicaldevices, #medicaltechnology , #biosimilars, and #pharmaceuticals by using #AI to seamlessly integrate suppliers' #commercial teams with buyers' #sourcingandprocurement teams, along with its related #processes. The #healthcare #ecosystem is in a critical condition, and we are building solutions that can improve #margins for everyone involved and reduce risks across the entire #supplychain.

42nd Annual J.P. Morgan Healthcare Conference has come and gone—but despite the packed rooms, there was a major elephant in the room that no one seemed to acknowledge. Not all companies can be winners. In our latest blog post, we dive deep into the industry's pulse to uncover crucial takeaways that were left unspoken. More than 42% of shutdown start-ups launched a product that showed little to no differentiation compared to existing commercial products—we’d say there is a serious problem on our hands. Ready to unlock the secrets that didn't make it to the conference floor? Learn more: https://loom.ly/k0PYh5U

At the recent AGS Health Partner Summit, our CEO, Patrice Wolfe, provided insights gained from the 42nd annual JP Morgan Healthcare Conference, highlighting five pivotal trends shaping the industry's trajectory. To learn more, read our recent blog diving into the current top priorities of leadership at large health systems and other healthcare organizations. https://hubs.la/Q02tCxMh0

An open house can be a game-changer for businesses, especially healthcare practices. 🏠✨ It’s a chance to showcase your services, expertise, and facilities to potential patients and the community. A well-executed event builds trust, boosts your practice, and attracts & retains patients. Here’s a formula to plan a successful healthcare open house ⬆️ Want the deets? Check our blog!

Curious how Pledge Health (YC W23) can save you hundreds of hours on benefits verifications and patient cost estimations? I will be at the Healthcare Business Management Association’s Fall conference in Austin next week. DM me if you will be in Austin next week and want to see Pledge in action!

Exciting news from #TeamDeanDorton! 📣 We are excited to build and strengthen relationships with the Florida Podiatric Medical Association (FPMA) members and practices! Interested in becoming an FPMA member? Check out the link below ⤵ #Healthcare #Consulting #Advisory

So, I am back from JPM Healthcare conference in SanFran.  It was a crazy week and a great experience. My 5 takeaways: (1) It is THE place to be for Pharma / Biotech partnering (2) Specifically for publicly traded organisations, presenting your company at the conference is a must to enforce your relevancy (3) The action is outside of the actual conference - majority of people don’t attend the conference but rather meet for business development, investment, or company analysis (4) Getting invited and attending the right evening receptions is even more critical than formal meetings. I had five receptions in one evening - could only make 3 of the 5 but they were worth it. (5) And MOST importantly, wear comfortable walking shoes and bring a good umbrella as you are moving between all the various hotels in central SanFran as you race to get to your next meeting. As mentioned previously, our BenevolentAI's Chairman & acting CEO, Francois Nader presented at the conference and did a fabulous job. He even mentioned my name as the Chief Revenue Officer in spearheading our way forward - quite an honour! The link to the recording is below.  In my PoV it is worth 20 minutes of your time. However, if you don't have time here is my recap: We are at the intersection of Pharma & Tech and  a pioneer & leader in AI-augmented drug discovery, enabled by the Benevolent Platform. We stand above our competition of AI in drug discovery as not only have we been doing it for 10 years, but we are also one of the rare platforms that has validated our approach via three ways : (1) Successful collaborations with AstraZeneca with TargetID and most recently Merck Healthcare KGaA with Chemistry. For AstraZeneca the products are in the pipeline and they're real. (2) We leveraged our indication expansion capabilities to identify Eli Lilly and Company's rheumatoid arthritis drug Olumiant (baricitinib) as a potential treatment for COVID-19, which received an emergency use authorisation from the US FDA in 2020; full approval in May 2022. (3) Our platform has generated 5 wholly owned products in a pipeline that looks like a traditional Biotech. Our lead asset BEN-8744 is an oral PDE10 inhibitor in Phase I which is a potential first-in-class option for ulcerative colitis. Our Business model offers multiple routes for value creation. In addition to our high potential R&D pipeline and our leading E2E Drug Discovery solutions mentioned above, we have a new expansion opportunity through suite of Knowledge Exploration tools that acting as a co-pilot for scientists, leverages bio-specific natural language processing (NLP) and large language models (LLM) to surface data, perform analysis, and give scientific recommendations to drive new insights and increase productivity. So, as you can see from above, this is a very exciting time for BenevolentAI and I am thrilled to be part of the journey! #JPM2024 #drugdiscovery #aidrugdiscovery #generativeai #researchanddevelopment

The best part about conferences that gather champions for change is running into real-life heroes in the hallways. If you don't know Aditi Mallick, MD and Bryan O. Buckley, DrPH, MPH, MBA 👉🏿 Follow them!👈🏿 They play pivotal roles in designing and building a healthcare system that delivers quality care for ALL!

Are you contemplating the idea of bringing a partner on board for your private healthcare practice? It's a big decision that can greatly impact the dynamics and success of your business. Check out our post for invaluable insights and essential considerations before making this important decision. https://bit.ly/3vTZHzO

Top tip! Hosting a healthcare congress is more than just the event days—it’s about building meaningful connections that start before the first session begins. Engaging healthcare professionals early on ensures that your congress isn’t just another event but a valuable opportunity for shared learning, collaboration, and impactful discussions. Download the whitepaper now: ‘The future of medical congress, and how to meet the needs of healthcare professionals’: https://lnkd.in/eKiytVvF #HCPengagement #OmnichannelMarketing #MedicalEvents